The Quarterly Performance of GSK’s Vaccines Segment
GlaxoSmithKline’s (GSK) Vaccines segment includes influenza vaccines, meningitis vaccines, Shingles vaccines, and established vaccines. The segment reported a 7% rise in YoY (year-over-year) revenue to ~1.2 billion British pounds during the first quarter. This rise followed a 13% rise in operating revenue offset by the 6% negative impact of foreign exchange during the quarter.